Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota.

IF 2.6 3区 医学 Q1 Pharmacology, Toxicology and Pharmaceutics
Therapeutics and Clinical Risk Management Pub Date : 2025-12-13 eCollection Date: 2025-01-01 DOI:10.2147/TCRM.S540144
Syed Arman Rabbani, Mohamed El-Tanani, Miodrag Janić, Andrej Janež, Yahia El Tanani, Eman Hajeer, Mohammad I Matalka, Manfredi Rizzo, Rakesh Kumar
{"title":"Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota.","authors":"Syed Arman Rabbani, Mohamed El-Tanani, Miodrag Janić, Andrej Janež, Yahia El Tanani, Eman Hajeer, Mohammad I Matalka, Manfredi Rizzo, Rakesh Kumar","doi":"10.2147/TCRM.S540144","DOIUrl":null,"url":null,"abstract":"<p><p>The human gut possesses a highly complex and metabolically functional microbial community. This microbial ecosystem, often termed a \"super-organism\", plays a critical function in regulating the host's metabolic processes, including gut motility, energy absorption, appetite, glucose and lipid metabolism, as well as hepatic fat storage. These metabolic functions of the gut microbiota (GM) play a central role in maintaining host homeostasis and overall metabolic health. This review synthesizes findings from recent clinical and preclinical studies, focusing on the interactions between gut microbiota, metabolic functions, and dietary interventions, to provide an evidence-based overview of current knowledge and future perspectives. Evidence was compiled through a narrative review of studies indexed in PubMed, Scopus, Web of Science, and Google Scholar using prespecified keywords related to gut microbiota, metabolic syndrome, diet, and dysbiosis.Recent advancements in nutritional science and microbiology have highlighted the substantial relation between the GM and multiple pathological conditions, including metabolic syndrome (MetS). A plethora of studies predict that disruptions in the GM, known as dysbiosis, may influence the progression of diabetes, obesity, and cardiovascular diseases (CVDs). Notably, elucidating the contributions of the GM in the pathogenesis of MetS could offer promising avenues for therapeutic interventions. Herein, we review the physiological and metabolic functions of the GM and its connection to MetS pathogenesis, while also highlighting the potential molecular mechanisms underlying these observed associations. Furthermore, we discuss the influence of different dietary approaches on MetS and the impact of nutritional therapeutic strategies to support the development of beneficial gut bacteria and alleviate dysbiosis. By integrating insights from both clinical and preclinical research, this study provides a comprehensive overview of how GM modulation can support metabolic health. The possibility of tailoring nutritional interventions based on individual microbiota profiles represents a promising frontier for personalized and effective approaches to improve metabolic health.</p>","PeriodicalId":22977,"journal":{"name":"Therapeutics and Clinical Risk Management","volume":"21 ","pages":"1701-1733"},"PeriodicalIF":2.6000,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713056/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutics and Clinical Risk Management","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/TCRM.S540144","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The human gut possesses a highly complex and metabolically functional microbial community. This microbial ecosystem, often termed a "super-organism", plays a critical function in regulating the host's metabolic processes, including gut motility, energy absorption, appetite, glucose and lipid metabolism, as well as hepatic fat storage. These metabolic functions of the gut microbiota (GM) play a central role in maintaining host homeostasis and overall metabolic health. This review synthesizes findings from recent clinical and preclinical studies, focusing on the interactions between gut microbiota, metabolic functions, and dietary interventions, to provide an evidence-based overview of current knowledge and future perspectives. Evidence was compiled through a narrative review of studies indexed in PubMed, Scopus, Web of Science, and Google Scholar using prespecified keywords related to gut microbiota, metabolic syndrome, diet, and dysbiosis.Recent advancements in nutritional science and microbiology have highlighted the substantial relation between the GM and multiple pathological conditions, including metabolic syndrome (MetS). A plethora of studies predict that disruptions in the GM, known as dysbiosis, may influence the progression of diabetes, obesity, and cardiovascular diseases (CVDs). Notably, elucidating the contributions of the GM in the pathogenesis of MetS could offer promising avenues for therapeutic interventions. Herein, we review the physiological and metabolic functions of the GM and its connection to MetS pathogenesis, while also highlighting the potential molecular mechanisms underlying these observed associations. Furthermore, we discuss the influence of different dietary approaches on MetS and the impact of nutritional therapeutic strategies to support the development of beneficial gut bacteria and alleviate dysbiosis. By integrating insights from both clinical and preclinical research, this study provides a comprehensive overview of how GM modulation can support metabolic health. The possibility of tailoring nutritional interventions based on individual microbiota profiles represents a promising frontier for personalized and effective approaches to improve metabolic health.

Abstract Image

Abstract Image

调节代谢健康和生理功能:针对肠道微生物群的饮食干预研究进展。
人体肠道具有高度复杂和代谢功能的微生物群落。这种微生物生态系统通常被称为“超级有机体”,在调节宿主的代谢过程中起着关键作用,包括肠道运动、能量吸收、食欲、葡萄糖和脂质代谢以及肝脏脂肪储存。肠道微生物群(GM)的这些代谢功能在维持宿主体内平衡和整体代谢健康方面起着核心作用。本综述综合了近期临床和临床前研究的结果,重点关注肠道微生物群、代谢功能和饮食干预之间的相互作用,以提供当前知识和未来观点的循证概述。证据是通过对PubMed、Scopus、Web of Science和谷歌Scholar检索的研究进行叙述性回顾,使用预先指定的与肠道微生物群、代谢综合征、饮食和生态失调相关的关键词。最近营养科学和微生物学的进展强调了转基因与多种病理状况之间的实质性关系,包括代谢综合征(MetS)。大量研究预测,被称为生态失调的转基因破坏可能会影响糖尿病、肥胖和心血管疾病(cvd)的进展。值得注意的是,阐明转基因在MetS发病机制中的作用可能为治疗干预提供有希望的途径。在此,我们回顾了GM的生理和代谢功能及其与MetS发病机制的联系,同时也强调了这些观察到的关联的潜在分子机制。此外,我们还讨论了不同饮食方式对MetS的影响,以及营养治疗策略对支持有益肠道细菌发育和缓解生态失调的影响。通过整合临床和临床前研究的见解,本研究提供了转基因调节如何支持代谢健康的全面概述。基于个体微生物群特征定制营养干预的可能性代表了改善代谢健康的个性化和有效方法的有前途的前沿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management HEALTH CARE SCIENCES & SERVICES-
CiteScore
5.30
自引率
3.60%
发文量
139
审稿时长
16 weeks
期刊介绍: Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas. The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature. As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication. The journal does not accept study protocols, animal-based or cell line-based studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书